These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10022535)

  • 1. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
    Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
    Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
    Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
    Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
    Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
    Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
    Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
    Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene.
    Curiel TJ; Cook DR; Wang Y; Hahn BH; Ghosh SK; Harrison GS
    Hum Gene Ther; 1993 Dec; 4(6):741-7. PubMed ID: 8186289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
    Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
    Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE; Ramezani A; Li X; Joshi S
    Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys.
    Smith C; Lee SW; Wong E; Gallardo H; Page K; Gaspar O; Lebkowski J; Gilboa E
    Antiviral Res; 1996 Oct; 32(2):99-115. PubMed ID: 8891169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.
    Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM
    Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.